FR2759290B1 - Minalcipran pour le traitement de l'incontinence urinaire - Google Patents

Minalcipran pour le traitement de l'incontinence urinaire

Info

Publication number
FR2759290B1
FR2759290B1 FR9701672A FR9701672A FR2759290B1 FR 2759290 B1 FR2759290 B1 FR 2759290B1 FR 9701672 A FR9701672 A FR 9701672A FR 9701672 A FR9701672 A FR 9701672A FR 2759290 B1 FR2759290 B1 FR 2759290B1
Authority
FR
France
Prior art keywords
minalcipran
treatment
urinary incontinence
incontinence
urinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9701672A
Other languages
English (en)
Other versions
FR2759290A1 (fr
Inventor
Jean Francois Prost
Alain Tournoux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR9701672A priority Critical patent/FR2759290B1/fr
Publication of FR2759290A1 publication Critical patent/FR2759290A1/fr
Application granted granted Critical
Publication of FR2759290B1 publication Critical patent/FR2759290B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9701672A 1997-02-13 1997-02-13 Minalcipran pour le traitement de l'incontinence urinaire Expired - Lifetime FR2759290B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9701672A FR2759290B1 (fr) 1997-02-13 1997-02-13 Minalcipran pour le traitement de l'incontinence urinaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701672A FR2759290B1 (fr) 1997-02-13 1997-02-13 Minalcipran pour le traitement de l'incontinence urinaire

Publications (2)

Publication Number Publication Date
FR2759290A1 FR2759290A1 (fr) 1998-08-14
FR2759290B1 true FR2759290B1 (fr) 2004-06-18

Family

ID=9503664

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9701672A Expired - Lifetime FR2759290B1 (fr) 1997-02-13 1997-02-13 Minalcipran pour le traitement de l'incontinence urinaire

Country Status (1)

Country Link
FR (1) FR2759290B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075886A1 (fr) 2003-02-14 2004-09-10 Pierre Fabre Medicament Utilisation de l’enantiomere (1s, 2r) du milnacipran pour la preparation d’un medicament
FR2851163B1 (fr) 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
CA2779711C (fr) 2009-11-06 2016-11-01 Forest Laboratories Holding Limited Nouvelles formes cristallines du (1s,2r)-2-(aminomethyl)-n,n-diethyl-1-phenylcyclopropanecarboxamide
US20120289744A1 (en) 2010-11-03 2012-11-15 Arch Pharmalabs Limited Process for preparing optically pure milnacipran and its pharmaceutically acceptable salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1415541A (en) * 1972-11-30 1975-11-26 Hexachimie 1-amino-methyl-2,2-diarylcyclopropanecarboxamide
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments

Also Published As

Publication number Publication date
FR2759290A1 (fr) 1998-08-14

Similar Documents

Publication Publication Date Title
FR2785521B1 (fr) Dispositif de suspension pour le traitement de prolapsus et d'incontinences urinaires
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
DE69725484D1 (de) Vorrichtung zur Behandlung von Harninkontinenz
DZ2396A1 (fr) Traitement de l'eau
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
DK84193A (da) Vaginalt autosutur-instrument til forhindring af urin-inkontinens hos kvinder
BR9710031A (pt) Tratamento de incontinência urinária utilizando (s)-Oxibutinina e (s)-Desetiloxibutinina
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
DE69527979D1 (de) Harninkontinenzvorrichtung
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
MA25411A1 (fr) Microorganismes attenues pour le traitement d'infection.
MA24332A1 (fr) Utilisation de 1-hydroxy-2- pyridones pour le traitement d'infections de la peau
FR2758465B1 (fr) Composition pour le traitement de l'amiante
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
MA23837A1 (fr) Benzamides pour le traitement de degenerescenses neurologiques
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
FR2759290B1 (fr) Minalcipran pour le traitement de l'incontinence urinaire
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
FR2801508B1 (fr) Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 20